Recombinant Vaccines against T. gondii: Comparison between Homologous and Heterologous Vaccination Protocols Using Two Viral Vectors Expressing SAG1

The use of recombinant viral vectors expressing T. gondii antigens is a safe and efficient approach to induce immune response against the parasite and a valuable tool for vaccine development. We have previously protected mice from toxoplasmosis by immunizing the animals with an adenovirus expressing...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Érica Araújo, Fonseca, Flavio G., Casério, Bárbara M., Colina, Janaína P., Gazzinelli, Ricardo Tostes, Caetano, Braulia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654925/
https://www.ncbi.nlm.nih.gov/pubmed/23690999
http://dx.doi.org/10.1371/journal.pone.0063201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654925/
https://www.ncbi.nlm.nih.gov/pubmed/23690999
http://dx.doi.org/10.1371/journal.pone.0063201

Ejemplares similares